Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$7,011,938
in 3 filings, $6.7M under 10b5-1 plans

Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. BAKER BROS. ADVISORS LP +$35.0M Director 1 filing
  2. Sibold William John −$6.2M President and CEO sold 6% of stake
  3. Kelley Shannon T −$773K General Counsel sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2026-01-09 Taub Rebecca Director Sale 10b5-1 −588 $521.95 $307K 464,462
2026-01-09 Taub Rebecca Director Sale 10b5-1 −732 $522.98 $383K 463,730
2026-01-09 Taub Rebecca Director Sale 10b5-1 −1,335 $524.06 $700K 462,395
2026-01-09 Taub Rebecca Director Sale 10b5-1 −1,489 $525.12 $782K 460,906
2026-01-09 Taub Rebecca Director Sale 10b5-1 −913 $526.05 $480K 459,993
2026-01-09 Taub Rebecca Director Sale 10b5-1 −1,135 $526.95 $598K 458,858
2026-01-09 Taub Rebecca Director Sale 10b5-1 −465 $528.16 $246K 458,393
2026-01-09 Taub Rebecca Director Sale 10b5-1 −554 $529.28 $293K 457,839
2026-01-09 Taub Rebecca Director Sale 10b5-1 −256 $530.45 $136K 457,583
2026-01-09 Taub Rebecca Director Sale 10b5-1 −30 $531.05 $16K 457,553
2026-01-09 Taub Rebecca Director Sale 10b5-1 −40 $532.50 $21K 457,513
2026-01-09 Taub Rebecca Director Sale 10b5-1 −271 $534.18 $145K 457,242
2026-01-09 Taub Rebecca Director Sale 10b5-1 −89 $534.93 $48K 457,153
2026-01-09 Taub Rebecca Director Sale 10b5-1 −299 $535.80 $160K 456,854
2026-01-09 Taub Rebecca Director Sale 10b5-1 −385 $536.88 $207K 456,469
2026-01-09 Taub Rebecca Director Sale 10b5-1 −40 $537.84 $22K 456,429
2026-01-09 Taub Rebecca Director Sale 10b5-1 −400 $539.26 $216K 456,029
2026-01-09 Taub Rebecca Director Sale 10b5-1 −40 $540.26 $22K 455,989
2026-01-09 Taub Rebecca Director Sale 10b5-1 −400 $542.72 $217K 455,589
2026-01-09 Taub Rebecca Director Option exercise · Stock Option (Right to Buy) 10b5-1 −18,410 240

Page 9 of 82 · 1,629 trades